Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited c
Molecular Weight:
493.60
Purity:
99.95
CAS Number:
[152459-95-5]
Formula:
C29H31N7O
Target:
Autophagy,Bcr-Abl,c-Kit,PDGFR,SARS-CoV
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted